| 原料品名 | Efinaconazole |
|---|---|
| 原料中文名称 | 艾氟康唑 |
| 英文别名 | (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidin-1-yl)-1-(1H-1,2,4-triazin-1-yl)butan-2-ol |
| 中文别名 | 艾菲康唑/艾氟康唑/;伊非那康唑杂质;艾菲康唑;艾氟康唑;艾菲康唑及相关杂质;艾氟康唑(API);JUBLIA; KP 103; KP103;艾菲康唑及杂质 |
| 化学名称 | (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylidenepiperidin-1-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol |
| 分子式 | C18H22F2N4O |
| 分子量 | 348.3902864 |
| CAS号 | 164650-44-6 |
| EINECS编号 | 暂无权限 |
| 结构式图片 | 暂无权限 |
| 美国DMF登记 | 暂无权限 |
供应商信息
| 企业名称 | Maithri Drugs Private Limited |
|---|---|
| 企业类型 | 生产商 |
| 地址 | 7-2-C24,Sanath Nagar (I.E.) Sanath Nagar Hyderabad Tg 500018 In |
| 国家/地区 | 印度 |
| 公司官网 | 暂无权限 |
| 公司联系电话 | 暂无权限 |
| 公司邮箱 | 暂无权限 |
| 公司简介 | Maithri Drugs Private Limited is a Private incorporated on 18 February 2013. It is classified as Non-govt company and is registered at Registrar of Companies, Hyderabad. Its authorized share capital is Rs. 10,000,000 and its paid up capital is Rs. 10,000,000. It is inolved in Manufacture of basic chemicals Maithri Drugs Private Limited's Annual General Meeting (AGM) was last held on 29 September 2019 and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 31 March 2019. Directors of Maithri Drugs Private Limited are Naga Vikas Chakilam, Naga Raju Chakilam and Satyanarayana Reddy Manne. |
| 备注 | 若未能联系上供应商，可在药智通发布求购信息（https://s.yaozh.com/Purchase/release），或联系药智通客服17318480790（微信同号） |
扩展信息
